A detailed history of Altiora Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Altiora Financial Group, LLC holds 638 shares of LLY stock, worth $540,277. This represents 0.14% of its overall portfolio holdings.

Number of Shares
638
Previous 597 6.87%
Holding current value
$540,277
Previous $464 Million 24.37%
% of portfolio
0.14%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $29,719 - $37,270
41 Added 6.87%
638 $578 Million
Q1 2024

Apr 18, 2024

SELL
$592.2 - $792.28 $9,475 - $12,676
-16 Reduced 2.61%
597 $464 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $83,505 - $98,441
159 Added 35.02%
613 $357 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $197,353 - $272,082
454 New
454 $244 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Altiora Financial Group, LLC Portfolio

Follow Altiora Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altiora Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altiora Financial Group, LLC with notifications on news.